Effects of antiepileptic drugs on glutamate release from rat and human neocortical synaptosomes

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 383, Issue 5, 2011, Pages 531-542

  Kammerer, M ^a   Brawek, B ^a   Freiman, T M ^a   Jackisch, R ^a   Feuerstein, Thomas J ^a,b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Antiepileptic drugs; Glutamate release; Human; Neocortical synaptosomes; Potassium; Veratridine

Indexed keywords

ANTICONVULSIVE AGENT; CALCIUM CHANNEL; CALCIUM ION; CARBAMAZEPINE; ETIRACETAM; GABAPENTIN; GLUTAMIC ACID; LAMOTRIGINE; PHENYTOIN; PREGABALIN; SODIUM ION; VALPROIC ACID; VERATRIDINE;

ADOLESCENT; ADULT; AGED; ANIMAL TISSUE; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; EXOCYTOSIS; FEMALE; HUMAN; HUMAN TISSUE; MALE; NEOCORTEX; NEUROTRANSMISSION; NEUROTRANSMITTER RELEASE; NONHUMAN; PRESCHOOL CHILD; PRESYNAPTIC NERVE; RAT; SCHOOL CHILD; SPECIES DIFFERENCE; SYNAPTOSOME;

ANIMALS; ANTICONVULSANTS; CELLS, CULTURED; EXOCYTOSIS; FEMALE; GLUTAMIC ACID; HUMANS; MALE; NEOCORTEX; RATS; RATS, WISTAR; SPECIES SPECIFICITY; SYNAPTIC TRANSMISSION; SYNAPTOSOMES;

EID: 79955704547     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00210-011-0620-3     Document Type: Article

References (42)

1. Ahmad S, Fowler LJ, Whitton PS (2005) Lamotrigine, carbamazepine and phenytoin differentially alter extracellular levels of 5-hydroxytryptamine, dopamine and amino acids. Epilepsy Res 63:141-149
2. Altman DG (1991) Statistics in medical journals: developments in the 1980s. Stat Med 10:1897-1913
3. Belliotti TR, Capiris T, Ekhato IV, Kinsora JJ, Field MJ, Heffner TG, Meltzer LT, Schwarz JB, Taylor CP, Thorpe AJ, Vartanian MG, Wise LD, Su T-Z, Weber ML, Wustrow DJ (2005) Structure-activity relationships of pregabalin and analogues that target the alpha2delta protein. J Med Chem 48:2294-2307 (Pubitemid 40516424)
4. Berry D, Millington C (2005) Analysis of pregabalin at therapeutic concentrations in human plasma/serum by reversed-phase HPLC. Ther Drug Monit 27:451-456 (Pubitemid 41098819)
5. 3H-glutamate release from human neocortical synaptosomes. Naunyn Schmiedeberg's Arch Pharmacol 379:361-369
6. 2+ uptake and amino acid neurotransmitter release in vitro. Epilepsia 28:378-382
7. Custer KL, Austin NS, Sullivan JM, Bajjalieh SM (2006) Synaptic vesicle protein 2 enhances release probability at quiescent synapses. J Neurosci 26:1303-1313 (Pubitemid 43237062)
8. +- binding benzofuran isophthalate: the effect of veratridine, ouabain, and alpha-latrotoxin. J Neurochem 61:818-825
9. Dooley DJ, Taylor CP, Donevan S, Feltner D (2007) Ca2+ channel alpha2delta ligands: novel modulators of neurotransmission. Trends Pharmacol Sci 28:75-82 (Pubitemid 46161838)
10. During MJ, Spencer DD (1993) Extracellular hippocampal glutamate and spontaneous seizure in the conscious human brain. Lancet 341:1607-1610 (Pubitemid 23175242)
11. 2delta-1 is a neuronal thrombospondin receptor responsible for excitatory CNS synaptogenesis. Cell 139:380-392
12. Humeau Y, Doussau F, Grant NJ, Poulain B (2000) How botulinum and tetanus neurotoxins block neurotransmitter release. Biochimie 82:427-446 (Pubitemid 30391899)
13. Johannessen SI, Battino D, Berry DJ, Bialer M, Kramer G, Tomson T, Patsalos PN (2003) Therapeutic drug monitoring of the newer antiepileptic drugs. Ther Drug Monit 25:347-363 (Pubitemid 36638181)
14. Kammerer M, Brawek B, Freiman TM, Jackisch R, Feuerstein TJ (2009) Species differences between the effects of antiepileptic drugs on glutamate release in rat and human neocortical synaptosomes. Naunyn-Schmiedeberg's Arch Pharmacol 379(Suppl 1):17
15. Landmark CJ (2007) Targets for antiepileptic drugs in the synapse. Med Sci Monit 13:RA1-RA7
16. Larkman AU, Jack JJ (1995) Synaptic plasticity: hippocampal LTP. Curr Opin Neurobiol 5:324-334
17. Levi G, Raiteri M (1993) Carrier-mediated release of neurotransmitters. Trends Neurosci 16:415-419 (Pubitemid 23283403)
18. Levi G, Gallo V, Raiteri M (1980) A reevaluation of veratridine as a tool for studying the depolarization-induced release of neurotransmitters from nerve endings. Neurochem Res 5:281-295 (Pubitemid 10134138)
19. Lingamaneni R, Hemmings HC Jr (1999) Effects of anticonvulsants on veratridine- and KCl-evoked glutamate release from rat cortical synaptosomes. Neurosci Lett 276:127-130 (Pubitemid 29525506)
20. 3H]glycine release from mouse spinal cord synaptosomes selectively labeled through GLYT2 transporters. J Neurochem 103:2439-2448
21. Lynch BA, Lambeng N, Nocka K, Kensel-Hammes P, Bajjalieh SM, Matagne A, Fuks B (2004) The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. Proc Natl Acad Sci USA 101:9861-9866 (Pubitemid 38869327)
22. 2+ and the release of glutamate from synaptosomes. Biochem Soc Trans 18:375-377
23. McMahon HT, Nicholls DG (1991) The bioenergetics of neurotransmitter release. Biochim Biophys Acta 1059:243-264
24. McMahon HT, Foran P, Dolly JO, Verhage M, Wiegant VM, Nicholls DG (1992) Tetanus toxin and botulinum toxins type A and B inhibit glutamate, gamma-aminobutyric acid, aspartate, and metenkephalin release from synaptosomes. Clues to the locus of action. J Biol Chem 267:21338-21343
25. Meldrum BS (1994) The role of glutamate in epilepsy and other CNS disorders. Neurology 44:S14-S23
26. Morris RG, Black AB, Harris AL, Batty AB, Sallustio BC (1998) Lamotrigine and therapeutic drug monitoring: retrospective survey following the introduction of a routine service. Br J Clin Pharmacol 46:547-551 (Pubitemid 28522118)
27. Mula M (2009) New antiepileptic drugs: molecular targets. Cent Nerv Syst Agents Med Chem 9:79-86
28. Nicholls DG (1993) The glutamatergic nerve terminal. Eur J Biochem 212:613-631
29. Raiteri M, Sala R, Fassio A, Rossetto O, Bonanno G (2000) Entrapping of impermeant probes of different size into nonpermeabilized synaptosomes as a method to study presynaptic mechanisms. J Neurochem 74:423-431 (Pubitemid 30012797)
30. +]: involvement of transporter reversal and mitochondrial calcium. J Neurochem 80:706-714
31. Schiavo G, Matteoli M, Montecucco C (2000) Neurotoxins affecting neuroexocytosis. Physiol Rev 80:717-766 (Pubitemid 30164948)
32. Schumacher TB, Beck H, Steinhauser C, Schramm J, Elger CE (1998) Effects of phenytoin, carbamazepine, and gabapentin on calcium channels in hippocampal granule cells from patients with temporal lobe epilepsy. Epilepsia 39:355-363 (Pubitemid 28158877)
33. 3H] glutamate in hippocampal nerve endings. Neuropharmacology 52:598-605
34. + channel-mediated release. Neuropharmacology 53:854-862
35. Stefan H, Feuerstein TJ (2007) Novel anticonvulsant drugs. Pharmacol Ther 113:165-183 (Pubitemid 46017070)
36. Stefani A, Spadoni F, Bernardi G (1997) Voltage-activated calcium channels: targets of antiepileptic drug therapy? Epilepsia 38:959-965
37. Taylor CP, Gee NS, Su T-Z, Kocsis JD,Welty DF, Brown JT, Dooley DJ, Boden P, Singh L (1998) A summary of mechanistic hypotheses of gabapentin pharmacology. Epilepsy Res 29:233-249 (Pubitemid 28137601)
38. 2delta subunit as a target for antiepileptic drug discovery. Epilepsy Res 73:137-150
39. Tuz K, Pena-Segura C, Franco R, Pasantes-Morales H (2004) Depolarization, exocytosis and amino acid release evoked by hyposmolarity from cortical synaptosomes. Eur J Neurosci 19:916-924 (Pubitemid 38297029)
40. Voso MT, Santini V, Finelli C, Musto P, Pogliani E, Angelucci E, Fioritoni G, Alimena G, Maurillo L, Cortelezzi A, Buccisano F, Gobbi M, Borin L, Di Tucci A, Zini G, Petti MC, Martinelli G, Fabiani E, Fazi P, Vignetti M, Piciocchi A, Liso V, Amadori S, Leone G (2009) Valproic acid at therapeutic plasma levels may increase 5-azacytidine efficacy in higher risk myelodysplastic syndromes. Clin Cancer Res 15:5002-5007
41. Waldmeier PC, Baumann PA, Wicki P, Feldtrauer JJ, Stierlin C, Schmutz M (1995) Similar potency of carbamazepine, oxcarbazepine, and lamotrigine in inhibiting the release of glutamate and other neurotransmitters. Neurology 45:1907-1913 (Pubitemid 27122967)
42. Wang S-J, Tsai J-J, Gean P-W (1997) Lamotrigine inhibits tetraethylammonium-induced synaptic plasticity in the rat amygdala. Neuroscience 81:667-671 (Pubitemid 27402514)